Compounds > 17 alpha-hydroxyprogesterone caproate
Page last updated: 2024-09-05

17 alpha-hydroxyprogesterone caproate and Adenoma, Prostatic

17 alpha-hydroxyprogesterone caproate has been researched along with Adenoma, Prostatic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BORA, R; GELLER, J; LIN, A; NEWMAN, H; ROBERTS, T; SILVA, R1
Braf, ZF; Brooks, ME1

Other Studies

2 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Adenoma, Prostatic

ArticleYear
TREATMENT OF BENIGN PROSTATIC HYPERTROPHY WITH HYDROXYPROGESTERONE CAPROATE: EFFECT ON CLINICAL SYMPTOMS, MORPHOLOGY, AND ENDOCRINE FUNCTION.
    JAMA, 1965, Jul-12, Volume: 193

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Biopsy; Drug Therapy; Gonadotropins; Gonadotropins, Pituitary; Humans; Hydroxyprogesterones; Luteinizing Hormone; Male; Pathology; Pituitary Gland; Prostatic Hyperplasia; Urine

1965
Effect of 17-alpha-hydroxyprogesterone 17-n-caproate on urine flow.
    Urology, 1981, Volume: 17, Issue:5

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Aged; Estrogen Antagonists; Humans; Hydroxyprogesterones; Male; Middle Aged; Progesterone Congeners; Prostatic Hyperplasia; Urination Disorders; Urodynamics

1981